21 related articles for article (PubMed ID: 30592062)
1. Uridine prevents fenofibrate-induced fatty liver.
Le TT; Urasaki Y; Pizzorno G
PLoS One; 2014; 9(1):e87179. PubMed ID: 24475249
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway.
Chen L; Peng J; Wang Y; Jiang H; Wang W; Dai J; Tang M; Wei Y; Kuang H; Xu G; Xu H; Zhou F
Am J Transl Res; 2020; 12(2):428-446. PubMed ID: 32194894
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion.
Cheng W; Wang M; Liu P; Zhao S; Liu X; Wang X
Med Sci Monit; 2019 Nov; 25():9073-9084. PubMed ID: 31782408
[TBL] [Abstract][Full Text] [Related]
4. The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat.
Pettersen JC; Pruimboom-Brees I; Francone OL; Amacher DE; Boldt SE; Kerlin RL; Ballinger WE
Toxicol Pathol; 2012 Apr; 40(3):435-47. PubMed ID: 22301950
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific transcriptional modulation of fatty acid-binding protein genes, fabp2, fabp3 and fabp6, by fatty acids and the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio).
Venkatachalam AB; Sawler DL; Wright JM
Gene; 2013 May; 520(1):14-21. PubMed ID: 23466978
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
[TBL] [Abstract][Full Text] [Related]
8. PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.
Qi Y; Jiang C; Tanaka N; Krausz KW; Brocker CN; Fang ZZ; Bredell BX; Shah YM; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G564-73. PubMed ID: 25035112
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
Wang D; Wang Y
Medicine (Baltimore); 2018 Apr; 97(14):e0318. PubMed ID: 29620657
[TBL] [Abstract][Full Text] [Related]
10. The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases.
Li B; Syed MH; Khan H; Singh KK; Qadura M
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140383
[TBL] [Abstract][Full Text] [Related]
11. Administration of Fenofibrate Markedly Elevates Fabp3 in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity.
Kochansky CJ; Lyman MJ; Fauty SE; Vlasakova K; D'mello AP
Lipids; 2018 Oct; 53(10):947-960. PubMed ID: 30592062
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
